Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

PROs are a Powerful Endpoint in TR Interventional Trials

Con: Rebuttal

Con: Earlier is Better - It Will Save Lives if We Do it Right?

Pro: For Symptoms Only - There is no Evidence for Other Benefit

Landscape of Transcatheter TR Therapies: A Lesion-Specific Approach?

Case Presentation: Atrial Secondary TR

The Role of Multimodality Imaging to Assess Patients With TR

Natural History and New Classification of Tricuspid Regurgitation